During the past decade, Beijing Youan Hospital, Capital Medical University conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.6% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 1 clinical trials were completed. i.e. 3.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Youan Hospital, Capital Medical University" #1 sponsor was "Beijing Friendship Hospital" with 13 trials, followed by "Nanfang Hospital of Southern Medical University" with 11 trials sponsored, "Xiamen Amoytop Biotech Co., Ltd." with 6 trials sponsored, "Beijing YouAn Hospital" with 5 trials sponsored and "Sunshine Lake Pharma Co., Ltd." with 5 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Youan Hospital, Capital Medical University" #1 collaborator was "Beijing YouAn Hospital" with 23 trials as a collaborator, "Beijing Ditan Hospital" with 13 trials as a collaborator, "Peking University First Hospital" with 11 trials as a collaborator, "Peking University People's Hospital" with 9 trials as a collaborator and "Beijing 302 Hospital" with 7 trials as a collaborator. Other collaborators include 250 different institutions and companies that were collaborators in the rest 152 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Youan Hospital, Capital Medical University" are "Chronic Hepatitis B" (10 trials), "Hepatitis B, Chronic" (10 trials), "Hepatitis B" (7 trials), "Liver Cirrhosis" (6 trials) and "Hepatocellular Carcinoma" (4 trials). Many other conditions were trialed in "Beijing Youan Hospital, Capital Medical University" in a lesser frequency.

Most popular intervention types in "Beijing Youan Hospital, Capital Medical University" are "Drug" (72 trials), "Biological" (11 trials), "Other" (9 trials), "Procedure" (7 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Entecavir" (5 trials), "Sofosbuvir" (4 trials), "TDF" (4 trials) and "Ypeginterferon alfa-2b" (4 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Youan Hospital, Capital Medical University" are 89 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Beijing Youan Hospital, Capital Medical University". 2 are not yet recruiting, 16 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Beijing Youan Hospital, Capital Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Youan Hospital, Capital Medical University, 8 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 9 trials that are defined as “Not Applicable".